A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study

Journal of Hypertension

Volumn 32, Issue 8, 2014, Pages 1621-1628

  Mallamaci, Francesca ^a,b   Testa, Alessandra ^a   Leonardis, Daniela ^a   Tripepi, Rocco ^a   Pisano, Anna ^a   Spoto, Belinda ^a   Sanguedolce, Maria Cristina ^a   Parlongo, Rosa Maria ^a   Tripepi, Giovanni ^a   Zoccali, Carmine ^a,b  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

genetic analysis; GLUT9 gene; hypertension; uric acid

Indexed keywords

GLUCOSE TRANSPORTER; URIC ACID; SLC2A9 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE MONITORING; ENVIRONMENTAL FACTOR; FAMILY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLOMERULUS FILTRATION RATE; GLUT9 GENE; HUMAN; HYPERURICEMIA; ITALY; MAJOR CLINICAL STUDY; MAJOR GENE; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLC2A9 GENE; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; WHITE COAT HYPERTENSION; ANIMAL; BLOOD; COMPLICATION; GENETICS; PHYSIOLOGY; SYSTOLE;

ANIMALS; BLOOD PRESSURE MONITORING, AMBULATORY; GENOTYPE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; HYPERURICEMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; SYSTOLE; URIC ACID; WHITE COAT HYPERTENSION;

EID: 84904065509     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000224     Document Type: Article

References (31)

1. Feig DI. Hyperuricemia and hypertension. Adv Chronic Kidney Dis 2012; 19:377-385.
2. Johnson RJ, Sanchez-Lozada LG, Mazzali M, Feig DI, Kanbay M, Sautin YY. What are the key arguments against uric acid as a true risk factor for hypertension? Hypertension 2013; 61:948-951.
3. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63:3136-3141.
4. Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 2004; 33:30-42. (Pubitemid 38528650)
5. Caulfield MJ, Munroe PB, O'Neill D, Witkowska K, Charchar FJ, Doblado M, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008; 5:e197.
6. Yang Q, Kottgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 2010; 3:523-530.
7. Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 2013; 45:145-154.
8. Benyamin B, Visscher PM, McRae AF. Family-based genome-wide association studies. Pharmacogenomics 2009; 10:181-190.
9. Parsa A, Brown E, Weir MR, Fink JC, Shuldiner AR, Mitchell BD, et al. Genotype-based changes in serum uric acid affect blood pressure. Kidney Int 2012; 81:502-507.
10. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Metaanalysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009; 5:e1000504.
11. Di Gaetano C, Voglino F, Guarrera S, Fiorito G, Rosa F, Di Blasio AM, et al. An overview of the genetic structure within the Italian population from genome-wide data. PLoS One 2012; 7:e43759.
12. Freisling H, Fahey MT, Moskal A, Ocke MC, Ferrari P, Jenab M, et al. Region-specific nutrient intake patterns exhibit a geographical gradient within and between European countries. J Nutr 2010; 140:1280-1286.
13. Castellano M, Glorioso N, Cusi D, Sarzani R, Fabris B, Opocher G, et al. Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: The GENIPER Project. J Hypertens 2003; 21:1853-1860. (Pubitemid 37290103)
14. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848. (Pubitemid 36677141)
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
16. Perticone F, Maio R, Tripepi G, Sciacqua A, Mallamaci F, Zoccali C. Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension. J Nephrol 2007; 20 (Suppl 12):s56-s62. (Pubitemid 351266139)
17. Cicero AF, Salvi P, D'Addato S, Rosticci M, Borghi C, Brisighella Heart Study group. Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. J Hypertens 2014; 32:57-64.
18. Yang J, Kamide K, Kokubo Y, Takiuchi S, Horio T, Matayoshi T, et al. Association of hypertension and its complications with variations of the xanthine dehydrogenase gene. Hypertens Res 2008; 31:931-940. (Pubitemid 351895038)
19. Sakurai H. Urate transporters in the genomic era. Curr Opin Nephrol Hypertens 2013; 22:545-550.
20. Bobulescu IA, Moe OW. Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis 2012; 19:358-371.
21. Matsuo H, Chiba T, Nagamori S, Nakayama A, Domoto H, Phetdee K, et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet 2008; 83:744-751.
22. Parati G, Mancia G. Assessing the white-coat effect: which blood pressure measurement should be considered? J Hypertens 2006; 24:29-31. (Pubitemid 41818082)
23. Mancia G, Fagard R, Narkiewicz K, Redan J, Zanchetti A, Bohm M, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 2013; 31:1925-1938.
24. Grassi G, Turri C, Vailati S, Dell'Oro R, Mancia G. Muscle and skin sympathetic nerve traffic during the 'white-coat' effect. Circulation 1999; 100:222-225. (Pubitemid 29340125)
25. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystalindependent mechanism. Hypertension 2001; 38:1101-1106. (Pubitemid 34252813)
26. Muldoon MF. White-coat hypertension and carotid artery atherosclerosis: A matching study. Arch Intern Med 2000; 160:1507-1512. (Pubitemid 30327456)
27. Afsar B. Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension. J Cardiol 2013; 61:222-621.
28. Grassi G. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens Res 2006; 29:839-847. (Pubitemid 46062115)
29. Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, et al., GenSalt Collaborative Research Group. Metabolic syndrome and salt sensitivity of blood pressure in nondiabetic people in China: A dietary intervention study. Lancet 2009; 373:829-835.
30. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serumuric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42:474-480. (Pubitemid 37237341)
31. Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40:355-360. (Pubitemid 35006723)